華媒控股(000607.SZ):華立集團及一致行動人擬減持不超5.99%股份
格隆匯11月20日丨華媒控股(000607.SZ)公佈,公司於2019年11月20日收到持股5%以上股東華立集團出具的《華立集團股份有限公司及其一致行動人關於計劃減持華媒控股股份的告知函》。合計持公司股份1.0121億股(佔公司總股本的9.95%)的股東華立集團及其一致行動人浙江華立投資管理、華立醫藥集團和華安未來資產-寧波銀行-華立集團計劃:
自該減持計劃公告之日起15個交易日之後的6個月內通過集中競價方式減持,自該減持計劃公告之日起3個交易日之後的6個月內通過大宗交易方式減持,合計減持公司股份不超過6100萬股,即不超過公司總股本的5.99%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.